General Catalyst led the equity portion of the £69m investment, which also features a debt facility from Trinity Capital.
"We have crossed 10,000 properties under management, placing Dwelly among the UK’s top 15 largest letting agencies in less than 2 years – an unseen speed of growth for letting agencies. Our vision is to build an end-to-end platform evolving into a fully transactional rental marketplace with a robust fintech layer for rent collection and ancillary products."
The Series A was led by GV with participation from Accel, Northzone, and other backers.
"Magic happens when companies get the exact technology they need. Enterprises are desperate to capitalize on the AI coding revolution, but nobody has built a product that reflects their reality – complex systems, strict standards, and global scale. SolveAI puts the power to build software directly in the hands of the people closest to the problems, without compromising security or compliance. Think about all the things you could achieve if your IT team could be everywhere at once: SolveAI makes this a reality."
The round was co-led by Eclipse, Balderton and SoftBank Vision Fund 2.
"We are making larger investments in high growth companies like Wayve to support the UK’s most promising businesses to start, scale, and stay in the UK."
The company completed an $18.5m total Seed round with backing from Cambridge Innovation Capital, UP.Partners, Insight Partners, and InMotion Ventures.
"Engineering teams require ever-faster, more flexible simulation, but do not have the technology to deliver on these demands. Generative physics introduces a fundamentally new approach to engineering, unlocking innovation across fields ranging from aerospace and automotive to data-centre design. We now have the capital and investor support to accelerate our research roadmap and scale commercial adoption. This could be the ChatGPT moment for physics."
The extension brings total Series C financing to £18.8m with participation from US investor Modi Ventures.
"This investment reflects strong confidence in our technology, our team, and the impact Brainomix 360 Stroke and e-Lung can have on patient care. Stroke care depends on speed, while lung fibrosis care requires early identification and consistent clinical decision-making over time, underscoring the need for hospital technologies that support clinicians at the point of care. With this investment extension, we are well-positioned to enhance customer support across the US and Europe, accelerating the seamless integration of our technology into existing clinical workflows and expanding access to life-saving treatments."
.png)
